Biotech entity

Cyclospora cayetanensis

pathogen

pharma is the sole category represented across all 3 tracked stories. Cyclospora cayetanensis is most often covered alongside Michigan Department of Health and Human Services, which appears in 2 of these 3 stories. Source depth averages 35 original sources per story, versus 7.2 across the same-window beat baseline.

Last mentioned: Jul 15, 2026

RSS updates
Share

Entity pulse

Recent coverage · Cyclospora cayetanensis

↑
3 stories
6 avg impact
0% positive
67% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 67 percentage points.

  • 33% neutral
  • 67% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Cyclospora cayetanensis

pharma is the sole category represented across all 3 tracked stories. Cyclospora cayetanensis is most often covered alongside Michigan Department of Health and Human Services, which appears in 2 of these 3 stories. Source depth averages 35 original sources per story, versus 7.2 across the same-window beat baseline. At 6, the average consequence score sits below the same-window beat average of 6.7. We currently track 3 Biotech stories that mention Cyclospora cayetanensis, published between July 11, 2026 and July 15, 2026.

Stories tracked
3
Sources per story
35

Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 37 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Cyclospora cayetanensis. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Cyclospora cayetanensis 3

Pharma Negative

5,100 Suspected Cyclospora Cases Drive Demand for Rapid Diagnostics and New Therapies

The CDC's health alert on a cyclosporiasis outbreak with 5,100 suspected cases presents urgent needs in the biotech sector for rapid diagnostics, antiparasitic drug development, and food safety technologies. The parasite Cyclospora cayetanensis, with its long incubation period, challenges traditional detection methods, while treatment relies on a decades-old antibiotic. Innovators could capitalize on multiplex PCR panels and next-generation sequencing for outbreak tracking.

75 sources

Source: 55krc.iheart.com · rocketerie.iheart.com

Cyclospora cayetanensis is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.